Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The Sleep Disorders Channel:
Narcolepsy

Welcome to The Narcolepsy Channel

VJNeurology brings you the latest updates in narcolepsy directly from world-leading experts. The Narcolepsy Channel brings you video interviews from international conferences.

Discover key developments in this space, including updates in disease biology, novel treatment strategies, and ongoing clinical trials.

Evolving understanding of orexin deficiency in narcolepsy type 1 and the impact of orexin agonists 2:50
Evolving understanding of orexin deficiency in narcolepsy type 1 and the impact of orexin agonists
Nancy Foldvary-Schaefer • 19 Jun 2026
Data on oveporexton and alixorexton in narcolepsy presented at SLEEP 2026 2:52
Data on oveporexton and alixorexton in narcolepsy presented at SLEEP 2026
Nancy Foldvary-Schaefer • 19 Jun 2026
Looking ahead to SLEEP 2026: highlights and key themes 3:09
Looking ahead to SLEEP 2026: highlights and key themes
Romy Hoque • 10 Jun 2026
Orexin agonists and the future of narcolepsy treatment 7:00
Orexin agonists and the future of narcolepsy treatment
Emmanuel Mignot • 30 Apr 2026
AI and sleep biomarkers for predicting cardiovascular and neurologic disease 6:53
AI and sleep biomarkers for predicting cardiovascular and neurologic disease
Emmanuel Mignot • 30 Apr 2026
Elevated influenza antibodies in recent-onset type-one narcolepsy 2:39
Elevated influenza antibodies in recent-onset type-one narcolepsy
Han Yan • 27 Apr 2026
The clinical potential of orexin-2 receptor agonists across sleep disorders 1:05
The clinical potential of orexin-2 receptor agonists across sleep disorders
Bruce Corser • 20 Apr 2026
Significant improvement in wakefulness with E2086 for narcolepsy: findings from a Phase I trial 2:08
Significant improvement in wakefulness with E2086 for narcolepsy: findings from a Phase I trial
Bruce Corser • 20 Apr 2026
Sleep highlights from EAN 2025: brain health and orexin agonists 2:23
Sleep highlights from EAN 2025: brain health and orexin agonists
Ambra Stefani • 23 Jun 2025
Advancing the understanding of narcolepsy pathology to improve patient quality of life 1:47
Advancing the understanding of narcolepsy pathology to improve patient quality of life
Emmanuel Mignot • 25 Sep 2024
The effects of a comprehensive rehabilitation program for patients with narcolepsy 3:38
The effects of a comprehensive rehabilitation program for patients with narcolepsy
Pitt Young • 26 Sep 2024
Increasing alertness using TAK-861 without the side effects associated with traditional therapies 1:39
Increasing alertness using TAK-861 without the side effects associated with traditional therapies
Emmanuel Mignot • 25 Sep 2024
Self-applied vs in-lab MSLT: a study for easier narcolepsy diagnosis and investigation 3:16
Self-applied vs in-lab MSLT: a study for easier narcolepsy diagnosis and investigation
Petar Chipev • 27 Sep 2024
The development of oral orexin receptor 2 agonists for the treatment of narcolepsy type 1 1:19
The development of oral orexin receptor 2 agonists for the treatment of narcolepsy type 1
Lucie Barateau • 27 Sep 2024
The five main symptoms of narcolepsy and cognitive dysfunction 2:31
The five main symptoms of narcolepsy and cognitive dysfunction
Lucie Barateau • 27 Sep 2024
An update on TAK-861 and orexin agonists in narcolepsy type 1 4:12
An update on TAK-861 and orexin agonists in narcolepsy type 1
Emmanuel Mignot • 25 Sep 2024

Choose your cookie settings

VJNeurology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJNeurology is intended for healthcare professionals